Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling

Biomaterials

Volumn 77, Issue , 2016, Pages 280-290

  Krieger, J R ^a   Ogle, M E ^a   McFaline Figueroa, J ^a   Segar, C E ^a   Temenoff, J S ^a,b   Botchwey, E A ^a,b  

^a EMORY UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Angiogenesis; Arteriogenesis; Hydrogel; Immunomodulation; SDF 1; Vascularization

Indexed keywords

BIOACTIVITY; BIOCHEMISTRY; BIOMATERIALS; BLOOD VESSELS; BODY FLUIDS; POLYETHYLENE GLYCOLS; POLYSACCHARIDES; REPAIR;

ANGIOGENESIS; ARTERIOGENESIS; IMMUNO MODULATIONS; SDF-1; VASCULARIZATION;

HYDROGELS;

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HEPARIN; POLY(ETHYLENE GLYCOL) DIACRYLATE; POLYMER; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; HYDROGEL; MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)DIACRYLATE; RECOMBINANT PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY MONOCYTE; ARTICLE; BONE MARROW CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HYDROGEL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; INNATE IMMUNITY; MALE; MICROSCOPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKINFOLD; VASCULAR REMODELING; ANGIOGENESIS; ANIMAL; ARTERIOLE; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; INTRAVITAL MICROSCOPY; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; RADIATION CHIMERA; REPORTER GENE; SKIN WINDOW TECHNIQUE; TRANSGENIC MOUSE; ULTRASTRUCTURE; WOUND HEALING;

ANIMALS; ARTERIOLES; BONE MARROW CELLS; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEPARIN; HYDROGELS; INFLAMMATION; INTRAVITAL MICROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROVESSELS; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENE GLYCOLS; RADIATION CHIMERA; RECOMBINANT PROTEINS; SKIN WINDOW TECHNIQUE; WOUND HEALING;

EID: 84949309995     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.10.045     Document Type: Article

References (50)

1. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
2. Hur J., Choi J.I., Yun J.Y., Yoon C.H., Jang J.H., Im S.G., et al. Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral blood. Biomaterials 2013, 34:1929-1941.
3. Patel A.S., Smith A., Nucera S., Biziato D., Saha P., Attia R.Q., et al. TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limb. EMBO Mol. Med. 2013, 5:858-869.
4. Shantsila E., Tapp L.D., Wrigley B.J., Montoro-Garcia S., Lip G.Y. CXCR4 positive and angiogenic monocytes in myocardial infarction. Thrombosis Haemostasis 2013, 109:255-262.
5. Zhang Z., Shively J.E. Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes. PloS One 2013, 8:e67649.
6. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
7. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
8. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
9. Aurora A.B., Porrello E.R., Tan W., Mahmoud A.I., Hill J.A., Bassel-Duby R., et al. Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 2014, 124:1382-1392.
10. Leuschner F., Rauch P.J., Ueno T., Gorbatov R., Marinelli B., Lee W.W., et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 2012, 209:123-137.
11. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037-3047.
12. Zhang Z., Shively J.E. Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PloS One 2010, 5:e13985.
13. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
14. Shechter R., Schwartz M. Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J. Pathology 2013, 229:332-346.
15. Godwin J.W., Pinto A.R., Rosenthal N.A. Macrophages are required for adult salamander limb regeneration. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:9415-9420.
16. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
17. Awojoodu A.O., Ogle M.E., Sefcik L.S., Bowers D.T., Martin K., Brayman K.L., et al. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:13785-13790.
18. Christoffersson G., Vagesjo E., Vandooren J., Liden M., Massena S., Reinert R.B., et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 2012, 120:4653-4662.
19. Ogle M.E., Sefcik L.S., Awojoodu A.O., Chiappa N.F., Lynch K., Peirce-Cottler S., et al. Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning. Acta Biomater. 2014, 10:4704-4714.
20. Stark K., Eckart A., Haidari S., Tirniceriu A., Lorenz M., von Bruhl M.L., et al. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat. Immunol. 2013, 14:41-51.
21. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
22. Omatsu Y., Seike M., Sugiyama T., Kume T., Nagasawa T. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature 2014, 508:536-540.
23. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
24. Zemani F., Silvestre J.S., Fauvel-Lafeve F., Bruel A., Vilar J., Bieche I., et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arteriosclerosis, Thrombosis, Vasc. Biol. 2008, 28:644-650.
25. Avraham-Davidi I., Yona S., Grunewald M., Landsman L., Cochain C., Silvestre J.S., et al. On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells. J. Exp. Med. 2013, 210:2611-2625.
26. Ehling J., Bartneck M., Wei X., Gremse F., Fech V., Mockel D., et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014, 63:1960-1971.
27. Hettiaratchi M.H., Miller T., Temenoff J.S., Guldberg R.E., McDevitt T.C. Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Biomaterials 2014, 35:7228-7238.
28. Seto S.P., Miller T., Temenoff J.S. Effect of selective heparin desulfation on preservation of bone morphogenetic protein-2 bioactivity after thermal stress. Bioconjugate Chem. 2015, 26:286-293.
29. Tellier L.E., Miller T., McDevitt T.C., Temenoff J.S. Hydrolysis and sulfation pattern effects on release of bioactive bone morphogenetic protein-2 from heparin-based microparticles. J. Mater. Chem. B 2015, 3:8001-8009.
30. Sadir R., Baleux F., Grosdidier A., Imberty A., Lortat-Jacob H. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 2001, 276:8288-8296.
31. Miller T., Goude M.C., McDevitt T.C., Temenoff J.S. Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery. Acta Biomater. 2014, 10:1705-1719.
32. Inoue Y., Nagasawa K. Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol. Carbohydr. Res. 1976, 46:87-95.
33. Hricovini M., Guerrini M., Bisio A., Torri G., Naggi A., Casu B. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution. Semin. Thromb. Hemost. 2002, 28:325-334.
34. Levy L., Petracek F.J. Chemical and pharmacological studies on N-resulfated heparin. Proc. Soc. Exp. Biol. Med. 1962, 109:901-905.
35. Nakamura S., Ishihara M., Obara K., Masuoka K., Ishizuka T., Kanatani Y., et al. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization. J. Biomed. Mater Res. A 2006, 78:364-371.
36. Roy S., Lai H., Zouaoui R., Duffner J., Zhou H., L P.J., et al. Bioactivity screening of partially desulfated low-molecular-weight heparins: a structure/activity relationship study. Glycobiology 2011, 21:1194-1205.
37. Hawe A., Friess W. Stabilization of a hydrophobic recombinant cytokine by human serum albumin. J. Pharm. Sci. 2007, 96:2987-2999.
38. Zamani M., Prabhakaran M.P., Thian E.S., Ramakrishna S. Controlled delivery of stromal derived factor-1alpha from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration. J. Colloid Interface Sci. 2015, 451:144-152.
39. Sefcik L.S., Aronin C.E., Awojoodu A.O., Shin S.J., Mac Gabhann F., MacDonald T.L., et al. Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth. Tissue Eng. Part A 2011, 17:617-629.
40. Sefcik L.S., Petrie Aronin C.E., Wieghaus K.A., Botchwey E.A. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials 2008, 29:2869-2877.
41. Bruce A.C., Kelly-Goss M.R., Heuslein J.L., Meisner J.K., Price R.J., Peirce S.M. Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model. Arteriosclerosis, Thrombosis, Vasc. Biol. 2014, 34:2012-2022.
42. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
43. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29:13435-13444.
44. Ratajczak M.Z., Kim C.H., Abdel-Latif A., Schneider G., Kucia M., Morris A.J., et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 2012, 26:63-72.
45. Ratajczak M.Z., Zuba-Surma E., Kucia M., Reca R., Wojakowski W., Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006, 20:1915-1924.
46. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 1998, 101:40-50.
47. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circulation Res. 1997, 80:829-837.
48. Troidl C., Jung G., Troidl K., Hoffmann J., Mollmann H., Nef H., et al. The temporal and spatial distribution of macrophage subpopulations during arteriogenesis. Curr. Vasc. Pharmacol. 2013, 11:5-12.
49. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
50. Takeda Y., Costa S., Delamarre E., Roncal C., Leite de Oliveira R., Squadrito M.L., et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011, 479:122-126.